Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
11,391,925
-
Share change
-
+220,353
-
Total reported value
-
$630,888,478
-
Price per share
-
$55.38
-
Number of holders
-
89
-
Value change
-
+$15,766,941
-
Number of buys
-
43
-
Number of sells
-
36
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2019
As of 31 Dec 2019 Krystal Biotech, Inc. - COMMON STOCK (KRYS) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,391,925 shares of stock of the company.
Largest 10 holders included FMR LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, and STATE STREET CORP.
This table shows 89 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.